Fusion Antibodies, a drug discovery spin-out of Queen’s University Belfast, will be able to further develop its capacity to produce cancer-fighting drugs following support from government agency Invest NI (Northern Ireland). The agency, which is distributing cash from the European Regional Development Fund, will put £63,304 ($103k) into the firm, of which £22,704 is earmarked…
Fusion moves forward with Invest NI
Nov 27, 2013 •
LEADERSHIP SOCIETYInforming, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
More featured content
Resistance is futile: seven superconductor companies that want to change the world
From healthcare to fusion to quantum computing to space, superconductors have the potential to revolutionise the world. And the technology is finally ready to commercialise.
UK universities urged to lower spinout stakes
A new report recommends stakes of less than 25% but fails to address the issue of access to early-stage capital.
Feb 7, 2024
Mar 14, 2024
Monterey, CA (USA)
Jun 26, 2024